De-identified serum specimens were tested in the Clinical Laboratory Improvement Amendment-certified clinical laboratory of Crescendo Bioscience (South San Francisco, CA, USA). A multiplexed, sandwich immunoassay (Mesoscale Discovery, Rockville, MD, USA) was used to measure concentrations of the 12 MBDA protein biomarkers: vascular cell adhesion molecule 1, epidermal growth factor, VEGF alpha, IL-6, TNF receptor-I, MMP-1, MMP-3, YKL-40, leptin, resistin, serum amyloid A and CRP. Concentration values were combined using a previously validated algorithm that generates an integer score on a scale of 1–100 [2 ]. Samples were tested from 2012 to 2017, using the same immunoassay instruments, reagents and algorithm as those used for the Vectra DA commercial test manufactured by Crescendo Bioscience.
Free full text: Click here